TRADING UPDATES: Netcall acquires Jadu for up to GBP19 million
10th Dec 2025 16:16
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 10.50p on 14-01-2026 at 15:05:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 11.00p |
| Sell | 10.00p |
| Last Trade: | Buy 7,374.00 at 10.72p |
| Day's Volume: | 12,065 |
| Last Close: | 10.50p |
| Open: | 10.50p |
| ISIN: | VGG042401262 |
| Day's Range | 10.50p - 10.50p |
| 52wk Range: | 6.25p - 29.00p |
| Market Capitalisation: | £5.43m |
| VWAP: | 10.71272p |
| Shares in Issue: | 51.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Crism Thera (CRTX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 7,374 | 10.72p | Ordinary |
14:31:07 - 14-Jan-26 |
| Sell* | 316 | 10.315p | Ordinary |
12:23:14 - 14-Jan-26 |
| Buy* | 1,629 | 10.74p | Ordinary |
09:43:43 - 14-Jan-26 |
| Buy* | 2,682 | 10.74p | Ordinary |
09:43:06 - 14-Jan-26 |
| Sell* | 64 | 10.00p | Ordinary |
08:32:05 - 14-Jan-26 |
| Sell* | 12 | 10.155p | Ordinary |
15:54:02 - 13-Jan-26 |
| Sell* | 2,111 | 10.315p | Ordinary |
11:32:57 - 13-Jan-26 |
| Buy* | 100 | 10.75p | Suspected BUY Trade |
10:43:39 - 13-Jan-26 |
| Buy* | 31,798 | 10.62p | Ordinary |
08:53:27 - 13-Jan-26 |
| Buy* | 145 | 11.00p | Ordinary |
08:34:19 - 13-Jan-26 |
Crism Thera (CRTX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Jan 2026 7:00 am | RNS | Results of Shareholder Analysis |
| 15th Dec 2025 2:29 pm | RNS | Result of Retail Offer |
| 10th Dec 2025 7:25 am | RNS | Retail Offer |
| 10th Dec 2025 7:00 am | RNS | Placing of £1,000,000 |
| 27th Nov 2025 7:00 am | RNS | Holding(s) in Company |
| 30th Oct 2025 7:00 am | RNS | US Orphan Drug Designation Application |
| 14th Oct 2025 7:00 am | RNS | Positive Preclinical Data in Prostate Cancer |
| 15th Sep 2025 7:00 am | RNS | Half Year Report |
| 12th Sep 2025 7:00 am | RNS | Notice of Interim Results and IMC Presentation |
| 1st Sep 2025 7:00 am | RNS | Approval for phase 2 clinical trial |